BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Synoradzki K, Grieb P. Citicoline: A Superior Form of Choline? Nutrients 2019;11:E1569. [PMID: 31336819 DOI: 10.3390/nu11071569] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Bekhet MA, Ali AA, Kharshoum RM, El-ela FIA, Salem HF. Intranasal Niosomal in situ Gel as a Novel Strategy for Improving Citicoline Efficacy and Brain Delivery in Treatment of Epilepsy: In vitro and ex vivo characterization and in vivo pharmacodynamics investigation. Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.xphs.2022.02.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Knapik JJ, Trone DW, Steelman RA, Farina EK, Lieberman HR. Adverse effects associated with use of specific dietary supplements: The US Military Dietary Supplement Use Study. Food Chem Toxicol 2022;:112840. [PMID: 35093428 DOI: 10.1016/j.fct.2022.112840] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gudi V, Schäfer N, Gingele S, Stangel M, Skripuletz T. Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and Remyelination. Pharmaceuticals (Basel) 2021;14:1156. [PMID: 34832936 DOI: 10.3390/ph14111156] [Reference Citation Analysis]
4 Castagna A, Fabbo A, Manzo C, Lacava R, Ruberto C, Ruotolo G. A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease. J Alzheimers Dis 2021;79:1509-15. [PMID: 33459645 DOI: 10.3233/JAD-201211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Goh YQ, Cheam G, Wang Y. Understanding Choline Bioavailability and Utilization: First Step Toward Personalizing Choline Nutrition. J Agric Food Chem 2021. [PMID: 34392687 DOI: 10.1021/acs.jafc.1c03077] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Grieb P, Świątkiewicz M, Kamińska A, Jünemann A, Rejdak R, Rejdak K. Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis. Pharmaceuticals (Basel) 2021;14:326. [PMID: 33918331 DOI: 10.3390/ph14040326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Jasielski P, Piędel F, Piwek M, Rocka A, Petit V, Rejdak K. Application of Citicoline in Neurological Disorders: A Systematic Review. Nutrients 2020;12:E3113. [PMID: 33053828 DOI: 10.3390/nu12103113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
8 Neumann EK, Migas LG, Allen JL, Caprioli RM, Van de Plas R, Spraggins JM. Spatial Metabolomics of the Human Kidney using MALDI Trapped Ion Mobility Imaging Mass Spectrometry. Anal Chem 2020;92:13084-91. [PMID: 32668145 DOI: 10.1021/acs.analchem.0c02051] [Cited by in Crossref: 12] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
9 Gandolfi S, Marchini G, Caporossi A, Scuderi G, Tomasso L, Brunoro A. Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma. Nutrients 2020;12:E793. [PMID: 32197303 DOI: 10.3390/nu12030793] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]